1. Home
  2. VTYX vs ZVIA Comparison

VTYX vs ZVIA Comparison

Compare VTYX & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • ZVIA
  • Stock Information
  • Founded
  • VTYX 2018
  • ZVIA 2007
  • Country
  • VTYX United States
  • ZVIA United States
  • Employees
  • VTYX N/A
  • ZVIA N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • VTYX Health Care
  • ZVIA Consumer Staples
  • Exchange
  • VTYX Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • VTYX 154.9M
  • ZVIA 142.5M
  • IPO Year
  • VTYX 2021
  • ZVIA 2021
  • Fundamental
  • Price
  • VTYX $1.70
  • ZVIA $2.72
  • Analyst Decision
  • VTYX Buy
  • ZVIA Hold
  • Analyst Count
  • VTYX 4
  • ZVIA 2
  • Target Price
  • VTYX $11.33
  • ZVIA $3.38
  • AVG Volume (30 Days)
  • VTYX 1.5M
  • ZVIA 797.4K
  • Earning Date
  • VTYX 05-08-2025
  • ZVIA 05-07-2025
  • Dividend Yield
  • VTYX N/A
  • ZVIA N/A
  • EPS Growth
  • VTYX N/A
  • ZVIA N/A
  • EPS
  • VTYX N/A
  • ZVIA N/A
  • Revenue
  • VTYX N/A
  • ZVIA $154,273,000.00
  • Revenue This Year
  • VTYX N/A
  • ZVIA $5.66
  • Revenue Next Year
  • VTYX N/A
  • ZVIA $6.76
  • P/E Ratio
  • VTYX N/A
  • ZVIA N/A
  • Revenue Growth
  • VTYX N/A
  • ZVIA N/A
  • 52 Week Low
  • VTYX $0.78
  • ZVIA $0.62
  • 52 Week High
  • VTYX $5.66
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 61.97
  • ZVIA 52.78
  • Support Level
  • VTYX $1.68
  • ZVIA $2.73
  • Resistance Level
  • VTYX $1.85
  • ZVIA $2.86
  • Average True Range (ATR)
  • VTYX 0.15
  • ZVIA 0.16
  • MACD
  • VTYX 0.04
  • ZVIA -0.02
  • Stochastic Oscillator
  • VTYX 67.05
  • ZVIA 21.82

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: